# DAPAGLIFLOZIN AND SAXAGLIPTIN

NDC: 72205-438
Generic name: DAPAGLIFLOZIN AND SAXAGLIPTIN
Labeler / Manufacturer: Novadoz Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20260406

FDA application: ANDA211533

## Active ingredients

- DAPAGLIFLOZIN: 10 mg/1
- SAXAGLIPTIN HYDROCHLORIDE DIHYDRATE: 5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72205-438"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72205-438
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1cfa51fd-8406-404c-b2a8-0fc1068675fb